William Blair resumed coverage of Sight Sciences (SGHT) with an Outperform rating and no price target The firm says the company in 2025 undertook several initiatives to accelerate sales growth and operating leverage. It sees potential upside to Sight’s 2026 consensus sales estimates.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGHT:
- Midday Fly By: JPMorgan reports mixed Q4, L3Harris to form new missile company
- Sight Sciences reports preliminary Q4 revenue $20.3M-$20.4M, consensus $20.17M
- Sight Sciences reports preliminary FY25 revenue $77.3M-$77.4M
- Piper Sandler upgrades Sight Sciences to Overweight, raises target to $9
- Sight Sciences upgraded to Overweight from Neutral at Piper Sandler